Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 25 | 2021 | 1203 | 3.560 |
Why?
|
Stroke Volume | 13 | 2021 | 456 | 3.040 |
Why?
|
Coronary Circulation | 4 | 2019 | 130 | 2.340 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 221 | 1.780 |
Why?
|
Cardiac Catheterization | 10 | 2019 | 291 | 1.760 |
Why?
|
Ventricular Function, Left | 9 | 2021 | 592 | 1.660 |
Why?
|
Ventricular Dysfunction, Left | 9 | 2018 | 318 | 1.520 |
Why?
|
Coronary Artery Disease | 8 | 2019 | 350 | 1.500 |
Why?
|
Aortic Valve Stenosis | 5 | 2020 | 131 | 1.470 |
Why?
|
Transcatheter Aortic Valve Replacement | 4 | 2020 | 47 | 1.420 |
Why?
|
Microvessels | 2 | 2019 | 70 | 1.320 |
Why?
|
Vascular Calcification | 2 | 2019 | 39 | 1.290 |
Why?
|
Microcirculation | 3 | 2023 | 106 | 1.280 |
Why?
|
Coronary Vessels | 3 | 2023 | 177 | 1.170 |
Why?
|
Thrombolytic Therapy | 3 | 2018 | 220 | 1.150 |
Why?
|
Percutaneous Coronary Intervention | 6 | 2019 | 58 | 1.050 |
Why?
|
Benzazepines | 6 | 2012 | 89 | 1.000 |
Why?
|
Hospitalization | 7 | 2015 | 848 | 0.960 |
Why?
|
Radial Artery | 4 | 2019 | 33 | 0.960 |
Why?
|
Renal Insufficiency | 3 | 2015 | 114 | 0.890 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2019 | 66 | 0.830 |
Why?
|
Heart-Assist Devices | 5 | 2021 | 731 | 0.760 |
Why?
|
Heart Diseases | 2 | 2016 | 290 | 0.750 |
Why?
|
Coronary Artery Bypass | 3 | 2019 | 228 | 0.750 |
Why?
|
Heart Arrest | 3 | 2018 | 265 | 0.730 |
Why?
|
Electrocardiography | 2 | 2019 | 478 | 0.710 |
Why?
|
Ventricular Pressure | 3 | 2021 | 34 | 0.700 |
Why?
|
ST Elevation Myocardial Infarction | 1 | 2019 | 11 | 0.700 |
Why?
|
Angiography, Digital Subtraction | 1 | 2019 | 91 | 0.700 |
Why?
|
Coronary Occlusion | 1 | 2019 | 7 | 0.690 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 58 | 0.690 |
Why?
|
Heart Neoplasms | 1 | 2019 | 62 | 0.670 |
Why?
|
Atherectomy, Coronary | 1 | 2018 | 2 | 0.670 |
Why?
|
Cardiac Catheters | 1 | 2018 | 9 | 0.670 |
Why?
|
Venous Thrombosis | 1 | 2021 | 243 | 0.670 |
Why?
|
Patient Readmission | 4 | 2017 | 329 | 0.660 |
Why?
|
Hemodynamics | 4 | 2021 | 710 | 0.650 |
Why?
|
Treatment Outcome | 20 | 2021 | 7988 | 0.640 |
Why?
|
Aged | 32 | 2020 | 18402 | 0.630 |
Why?
|
Humans | 66 | 2023 | 86601 | 0.620 |
Why?
|
Antidiuretic Hormone Receptor Antagonists | 4 | 2012 | 29 | 0.610 |
Why?
|
Triage | 1 | 2018 | 108 | 0.610 |
Why?
|
Echocardiography | 5 | 2018 | 911 | 0.610 |
Why?
|
Myocardium | 3 | 2018 | 529 | 0.600 |
Why?
|
Etiocholanolone | 4 | 2009 | 5 | 0.590 |
Why?
|
Cardio-Renal Syndrome | 2 | 2019 | 6 | 0.580 |
Why?
|
Device Removal | 1 | 2018 | 161 | 0.580 |
Why?
|
Decision Support Techniques | 1 | 2018 | 160 | 0.580 |
Why?
|
Female | 44 | 2021 | 44507 | 0.560 |
Why?
|
Retrospective Studies | 16 | 2021 | 8475 | 0.560 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 202 | 0.560 |
Why?
|
Postoperative Complications | 2 | 2017 | 2207 | 0.550 |
Why?
|
Male | 41 | 2021 | 40956 | 0.540 |
Why?
|
Endoscopy | 1 | 2019 | 332 | 0.540 |
Why?
|
Middle Aged | 36 | 2021 | 25017 | 0.530 |
Why?
|
Point-of-Care Systems | 4 | 2008 | 141 | 0.530 |
Why?
|
Aged, 80 and over | 15 | 2020 | 6501 | 0.520 |
Why?
|
Cardiomyopathies | 1 | 2017 | 240 | 0.500 |
Why?
|
Creatinine | 1 | 2015 | 338 | 0.500 |
Why?
|
Coronary Angiography | 7 | 2023 | 232 | 0.470 |
Why?
|
Cardiotonic Agents | 3 | 2009 | 87 | 0.470 |
Why?
|
Kidney | 2 | 2019 | 1241 | 0.470 |
Why?
|
Thrombosis | 1 | 2016 | 296 | 0.450 |
Why?
|
Neurotransmitter Agents | 2 | 2019 | 106 | 0.450 |
Why?
|
Ischemia | 3 | 2020 | 243 | 0.440 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 2600 | 0.440 |
Why?
|
Risk Factors | 7 | 2021 | 5416 | 0.400 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2019 | 139 | 0.370 |
Why?
|
Myocardial Ischemia | 2 | 2023 | 162 | 0.370 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 1673 | 0.370 |
Why?
|
Popliteal Artery | 2 | 2020 | 27 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 1074 | 0.370 |
Why?
|
Absorbable Implants | 2 | 2020 | 34 | 0.360 |
Why?
|
Angioplasty, Balloon | 2 | 2020 | 95 | 0.350 |
Why?
|
Peripheral Arterial Disease | 2 | 2020 | 88 | 0.340 |
Why?
|
Vascular Resistance | 2 | 2019 | 102 | 0.340 |
Why?
|
Prognosis | 9 | 2019 | 3674 | 0.330 |
Why?
|
Vasopressins | 1 | 2008 | 49 | 0.330 |
Why?
|
Weight Gain | 1 | 2009 | 123 | 0.320 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 183 | 0.320 |
Why?
|
Echocardiography, Transesophageal | 4 | 2019 | 344 | 0.310 |
Why?
|
Amyloidosis | 1 | 2009 | 115 | 0.310 |
Why?
|
Biomarkers | 6 | 2019 | 1718 | 0.310 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 860 | 0.300 |
Why?
|
Angina Pectoris | 2 | 2023 | 28 | 0.300 |
Why?
|
Spironolactone | 2 | 2021 | 23 | 0.290 |
Why?
|
Pulmonary Wedge Pressure | 5 | 2021 | 108 | 0.290 |
Why?
|
Hospital Mortality | 2 | 2021 | 348 | 0.280 |
Why?
|
Cardiovascular Agents | 3 | 2012 | 56 | 0.280 |
Why?
|
Heart | 4 | 2019 | 539 | 0.280 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2019 | 190 | 0.270 |
Why?
|
Causality | 2 | 2017 | 81 | 0.260 |
Why?
|
Prospective Studies | 7 | 2019 | 4210 | 0.260 |
Why?
|
Echocardiography, Three-Dimensional | 3 | 2019 | 516 | 0.250 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 3 | 2009 | 78 | 0.250 |
Why?
|
Double-Blind Method | 6 | 2012 | 1823 | 0.240 |
Why?
|
Myocardial Bridging | 1 | 2023 | 3 | 0.240 |
Why?
|
Time Factors | 6 | 2020 | 5209 | 0.240 |
Why?
|
Vena Cava, Inferior | 4 | 2008 | 143 | 0.220 |
Why?
|
Kidney Function Tests | 2 | 2015 | 123 | 0.210 |
Why?
|
Mineralocorticoid Receptor Antagonists | 3 | 2021 | 59 | 0.210 |
Why?
|
Heart Atria | 3 | 2016 | 250 | 0.210 |
Why?
|
Blood Pressure | 4 | 2008 | 1143 | 0.210 |
Why?
|
Myocardial Revascularization | 2 | 2014 | 31 | 0.200 |
Why?
|
Comorbidity | 2 | 2017 | 943 | 0.200 |
Why?
|
Catheters | 1 | 2021 | 74 | 0.200 |
Why?
|
Lower Extremity | 1 | 2021 | 84 | 0.200 |
Why?
|
Equipment Failure | 2 | 2018 | 119 | 0.190 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2020 | 5 | 0.190 |
Why?
|
Reproducibility of Results | 5 | 2018 | 2705 | 0.190 |
Why?
|
Risk Assessment | 6 | 2020 | 2261 | 0.190 |
Why?
|
Severity of Illness Index | 4 | 2019 | 1801 | 0.190 |
Why?
|
Equipment Design | 3 | 2018 | 406 | 0.190 |
Why?
|
Fibrosis | 2 | 2020 | 203 | 0.180 |
Why?
|
Punctures | 1 | 2019 | 29 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2019 | 4 | 0.180 |
Why?
|
Mitral Valve | 2 | 2018 | 248 | 0.180 |
Why?
|
Survival Rate | 3 | 2020 | 1860 | 0.180 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 96 | 0.180 |
Why?
|
Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.170 |
Why?
|
Septal Occluder Device | 1 | 2019 | 42 | 0.170 |
Why?
|
United States | 5 | 2019 | 6665 | 0.170 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2019 | 67 | 0.170 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2009 | 56 | 0.170 |
Why?
|
Illinois | 2 | 2018 | 462 | 0.170 |
Why?
|
Chronic Disease | 2 | 2019 | 970 | 0.170 |
Why?
|
Radiation Dosage | 1 | 2019 | 227 | 0.170 |
Why?
|
Follow-Up Studies | 5 | 2019 | 3636 | 0.170 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 16 | 0.170 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2018 | 23 | 0.160 |
Why?
|
Fatal Outcome | 1 | 2019 | 293 | 0.160 |
Why?
|
Hospitals | 1 | 2021 | 294 | 0.160 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 806 | 0.160 |
Why?
|
rho-Associated Kinases | 1 | 2020 | 159 | 0.160 |
Why?
|
Disease Progression | 2 | 2015 | 1531 | 0.160 |
Why?
|
Atrial Function, Left | 1 | 2018 | 46 | 0.160 |
Why?
|
Hospital Costs | 1 | 2019 | 104 | 0.160 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2018 | 47 | 0.160 |
Why?
|
Monocytes | 1 | 2019 | 214 | 0.160 |
Why?
|
Myocardial Infarction | 3 | 2014 | 375 | 0.160 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2019 | 67 | 0.160 |
Why?
|
Hydroxyethylrutoside | 1 | 2017 | 1 | 0.160 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 266 | 0.150 |
Why?
|
Blood Circulation | 1 | 2017 | 29 | 0.150 |
Why?
|
Heart Massage | 1 | 2017 | 12 | 0.150 |
Why?
|
Allografts | 1 | 2018 | 172 | 0.150 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 166 | 0.150 |
Why?
|
Renal Veins | 1 | 2017 | 28 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 3352 | 0.150 |
Why?
|
Foreign-Body Migration | 1 | 2017 | 35 | 0.140 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 187 | 0.140 |
Why?
|
Macrophages | 1 | 2019 | 554 | 0.140 |
Why?
|
Organ Dysfunction Scores | 1 | 2016 | 27 | 0.140 |
Why?
|
Ultrasonography | 5 | 2009 | 695 | 0.140 |
Why?
|
Health Status | 1 | 2018 | 360 | 0.140 |
Why?
|
Upper Extremity | 1 | 2016 | 52 | 0.140 |
Why?
|
Blood Flow Velocity | 2 | 2014 | 197 | 0.130 |
Why?
|
Catheterization | 1 | 2017 | 232 | 0.130 |
Why?
|
Fibromuscular Dysplasia | 1 | 2015 | 11 | 0.130 |
Why?
|
Vena Cava Filters | 1 | 2017 | 96 | 0.130 |
Why?
|
Quality of Life | 1 | 2023 | 1583 | 0.130 |
Why?
|
Coronary Aneurysm | 1 | 2015 | 16 | 0.130 |
Why?
|
Aortic Valve | 1 | 2017 | 222 | 0.130 |
Why?
|
Incidence | 2 | 2017 | 1576 | 0.130 |
Why?
|
Hemostatic Techniques | 1 | 2014 | 14 | 0.130 |
Why?
|
Shock, Cardiogenic | 1 | 2016 | 94 | 0.130 |
Why?
|
Hemoptysis | 1 | 2014 | 24 | 0.130 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 1565 | 0.130 |
Why?
|
Contrast Media | 1 | 2019 | 1077 | 0.120 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 12 | 0.120 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 462 | 0.120 |
Why?
|
Chicago | 2 | 2017 | 1379 | 0.120 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 81 | 0.120 |
Why?
|
Heart Ventricles | 1 | 2019 | 760 | 0.120 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2015 | 87 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2017 | 663 | 0.120 |
Why?
|
Intraoperative Complications | 1 | 2015 | 185 | 0.120 |
Why?
|
Urbanization | 1 | 2013 | 7 | 0.120 |
Why?
|
Longitudinal Studies | 1 | 2017 | 1019 | 0.120 |
Why?
|
Developed Countries | 1 | 2013 | 24 | 0.120 |
Why?
|
Case-Control Studies | 1 | 2018 | 1804 | 0.110 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 28 | 0.110 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 1990 | 0.110 |
Why?
|
Graft Rejection | 1 | 2019 | 1065 | 0.110 |
Why?
|
Patient Discharge | 1 | 2015 | 300 | 0.110 |
Why?
|
North America | 1 | 2013 | 180 | 0.110 |
Why?
|
Software | 1 | 2017 | 654 | 0.110 |
Why?
|
Canada | 1 | 2013 | 204 | 0.110 |
Why?
|
Heart Transplantation | 1 | 2018 | 705 | 0.110 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2015 | 208 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 827 | 0.110 |
Why?
|
Dyspnea | 2 | 2010 | 73 | 0.110 |
Why?
|
Kidney Transplantation | 1 | 2019 | 849 | 0.110 |
Why?
|
Hypotension | 1 | 2012 | 70 | 0.100 |
Why?
|
Coronary Disease | 1 | 2013 | 261 | 0.100 |
Why?
|
Adolescent | 3 | 2017 | 8979 | 0.100 |
Why?
|
Adult | 7 | 2019 | 25640 | 0.100 |
Why?
|
Heart Rate | 3 | 2008 | 492 | 0.100 |
Why?
|
Systole | 2 | 2008 | 129 | 0.100 |
Why?
|
Recurrence | 2 | 2011 | 1139 | 0.100 |
Why?
|
Vascular Patency | 2 | 2020 | 126 | 0.090 |
Why?
|
Acute Disease | 5 | 2009 | 826 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 384 | 0.090 |
Why?
|
Respiratory System Agents | 1 | 2009 | 7 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 59 | 0.090 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 21 | 0.090 |
Why?
|
Amyloid | 1 | 2009 | 85 | 0.090 |
Why?
|
Prevalence | 1 | 2013 | 1239 | 0.090 |
Why?
|
Smoking | 1 | 2013 | 609 | 0.080 |
Why?
|
Cardiology | 1 | 2010 | 123 | 0.080 |
Why?
|
Internationality | 1 | 2008 | 69 | 0.080 |
Why?
|
Assisted Circulation | 1 | 2008 | 15 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 1376 | 0.080 |
Why?
|
Ventricular Function | 1 | 2008 | 53 | 0.080 |
Why?
|
Diastole | 3 | 2018 | 144 | 0.080 |
Why?
|
Prosthesis Design | 2 | 2019 | 278 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2008 | 87 | 0.080 |
Why?
|
Atrial Function | 1 | 2007 | 17 | 0.080 |
Why?
|
Remission Induction | 1 | 2009 | 722 | 0.080 |
Why?
|
Brachial Artery | 1 | 2007 | 36 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 2007 | 90 | 0.070 |
Why?
|
Critical Care | 1 | 2010 | 370 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2009 | 326 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2007 | 121 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2007 | 97 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2008 | 460 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 2007 | 116 | 0.070 |
Why?
|
Obesity | 1 | 2013 | 963 | 0.070 |
Why?
|
ROC Curve | 1 | 2008 | 752 | 0.070 |
Why?
|
Physical Examination | 1 | 2007 | 149 | 0.070 |
Why?
|
Societies, Medical | 1 | 2010 | 572 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2014 | 1267 | 0.070 |
Why?
|
Ambulatory Care Facilities | 1 | 2006 | 102 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2007 | 334 | 0.060 |
Why?
|
Hypertension | 1 | 2013 | 1141 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 1961 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2006 | 355 | 0.060 |
Why?
|
Program Development | 1 | 2023 | 124 | 0.060 |
Why?
|
Life Style | 1 | 2023 | 189 | 0.050 |
Why?
|
Length of Stay | 2 | 2019 | 700 | 0.050 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2021 | 25 | 0.050 |
Why?
|
Internship and Residency | 2 | 2007 | 1004 | 0.050 |
Why?
|
Limb Salvage | 1 | 2020 | 31 | 0.050 |
Why?
|
Vascular Stiffness | 1 | 2020 | 26 | 0.050 |
Why?
|
Propensity Score | 1 | 2020 | 136 | 0.050 |
Why?
|
Frail Elderly | 1 | 2020 | 71 | 0.040 |
Why?
|
Algorithms | 3 | 2017 | 1830 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 274 | 0.040 |
Why?
|
Expert Testimony | 1 | 2019 | 46 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2019 | 119 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2019 | 36 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2021 | 305 | 0.040 |
Why?
|
Isoenzymes | 1 | 2020 | 271 | 0.040 |
Why?
|
American Heart Association | 1 | 2019 | 92 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 138 | 0.040 |
Why?
|
Endocardium | 1 | 2018 | 76 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2018 | 96 | 0.040 |
Why?
|
Antigens, CD | 1 | 2019 | 458 | 0.040 |
Why?
|
Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2019 | 237 | 0.040 |
Why?
|
Phlebography | 1 | 2017 | 66 | 0.040 |
Why?
|
Animals | 3 | 2020 | 26581 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 451 | 0.040 |
Why?
|
Cannula | 1 | 2016 | 47 | 0.030 |
Why?
|
Education, Medical | 1 | 2019 | 233 | 0.030 |
Why?
|
Databases, Factual | 1 | 2019 | 812 | 0.030 |
Why?
|
Aorta | 1 | 2017 | 280 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 589 | 0.030 |
Why?
|
Registries | 1 | 2019 | 702 | 0.030 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2014 | 11 | 0.030 |
Why?
|
Pulmonary Alveoli | 1 | 2014 | 71 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2015 | 148 | 0.030 |
Why?
|
Biopsy | 1 | 2018 | 1161 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2015 | 187 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 46 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 134 | 0.030 |
Why?
|
Image Enhancement | 1 | 2017 | 563 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 1169 | 0.030 |
Why?
|
Furosemide | 1 | 2012 | 33 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 1538 | 0.030 |
Why?
|
Diuretics | 1 | 2012 | 124 | 0.030 |
Why?
|
Infant | 1 | 2018 | 3045 | 0.030 |
Why?
|
Sodium | 1 | 2012 | 341 | 0.020 |
Why?
|
Administration, Oral | 1 | 2012 | 684 | 0.020 |
Why?
|
Edema, Cardiac | 1 | 2010 | 3 | 0.020 |
Why?
|
Physical Exertion | 1 | 2010 | 39 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2010 | 33 | 0.020 |
Why?
|
Dizziness | 1 | 2010 | 27 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 894 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 105 | 0.020 |
Why?
|
Pulmonary Atelectasis | 1 | 2009 | 18 | 0.020 |
Why?
|
Europe | 1 | 2010 | 309 | 0.020 |
Why?
|
Dobutamine | 1 | 2009 | 61 | 0.020 |
Why?
|
Signal Transduction | 1 | 2020 | 3241 | 0.020 |
Why?
|
Cause of Death | 1 | 2010 | 277 | 0.020 |
Why?
|
Syndrome | 1 | 2009 | 446 | 0.020 |
Why?
|
Heart, Artificial | 1 | 2008 | 9 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2007 | 63 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 429 | 0.020 |
Why?
|
Body Surface Area | 1 | 2007 | 36 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2007 | 41 | 0.020 |
Why?
|
Jugular Veins | 1 | 2007 | 69 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 80 | 0.020 |
Why?
|
Cardiac Output | 1 | 2007 | 156 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2007 | 197 | 0.020 |
Why?
|
Odds Ratio | 1 | 2008 | 678 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2007 | 102 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 916 | 0.020 |
Why?
|
Mice | 1 | 2020 | 11352 | 0.020 |
Why?
|
Observer Variation | 1 | 2007 | 602 | 0.020 |
Why?
|
Organ Size | 1 | 2006 | 364 | 0.020 |
Why?
|
Logistic Models | 1 | 2008 | 1185 | 0.020 |
Why?
|
Patient Selection | 1 | 2008 | 685 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2006 | 751 | 0.020 |
Why?
|